Longitudinal ctDNA monitoring for post-surgical molecular residual disease in patients with stage I-IIIb melanoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback